Editas Medicine, Inc. - Common Stock (EDIT)

CUSIP: 28106W103

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / Common Stock
Shares outstanding
82,773,190
Total 13F shares
31,152,906
Share change
+545,611
Total reported value
$1,032,691,989
Put/Call ratio
69%
Price per share
$33.15
Number of holders
192
Value change
+$25,997,611
Number of buys
126
Number of sells
44

Quarterly Holders Quick Answers

What is CUSIP 28106W103?
CUSIP 28106W103 identifies EDIT - Editas Medicine, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of EDIT - Editas Medicine, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
5.6%
4,622,720
$142,056,000 31 Dec 2017
13F
VANGUARD GROUP INC
13F
Company
3.3%
2,768,403
$85,074,000 31 Dec 2017
13F
BlackRock Finance, Inc.
13F
Company
3.2%
2,672,556
$82,129,000 31 Dec 2017
13F
STATE STREET CORP
13F
Company
2.9%
2,405,862
$73,934,000 31 Dec 2017
13F
Capital World Investors
13F
Company
2.1%
1,770,000
$54,392,000 31 Dec 2017
13F
VIKING GLOBAL INVESTORS LP
13F
Company
2.1%
1,709,401
$52,530,000 31 Dec 2017
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
2.1%
1,709,400
$52,530,000 31 Dec 2017
13F
Flagship Pioneering, LLC
13F
Company
2%
1,674,435
$51,455,000 31 Dec 2017
13F
ARK Investment Management LLC
13F
Company
1.3%
1,112,845
$34,198,000 31 Dec 2017
13F
TRV GP III, LLC
13F
Company
1.1%
906,176
$27,847,000 31 Dec 2017
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.1%
897,671
$27,585,000 31 Dec 2017
13F
MORGAN STANLEY
13F
Company
0.75%
622,019
$19,114,000 31 Dec 2017
13F
Global Thematic Partners, LLC
13F
Company
0.74%
614,052
$18,869,000 31 Dec 2017
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.62%
515,000
$15,826,000 31 Dec 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.51%
422,757
$12,991,000 31 Dec 2017
13F
CREDIT SUISSE AG/
13F
Company
0.45%
375,287
$11,532,000 31 Dec 2017
13F
NORTHERN TRUST CORP
13F
Company
0.45%
373,507
$11,478,000 31 Dec 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.44%
368,323
$11,319,000 31 Dec 2017
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.37%
302,960
$9,310,000 31 Dec 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.35%
289,855
$8,907,000 31 Dec 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.34%
282,286
$8,674,000 31 Dec 2017
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.3%
246,201
$7,565,757 31 Dec 2017
13F
D. E. Shaw & Co., Inc.
13F
Company
0.3%
245,118
$7,532,000 31 Dec 2017
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.26%
216,906
$6,665,000 31 Dec 2017
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.21%
174,135
$5,351,000 31 Dec 2017
13F
Bank of New York Mellon Corp
13F
Company
0.19%
159,301
$4,895,000 31 Dec 2017
13F
PKO Investment Management Joint-Stock Co
13F
Company
0.18%
150,892
$4,636,911 31 Dec 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.18%
145,526
$4,470,000 31 Dec 2017
13F
Allianz Asset Management GmbH
13F
Company
0.17%
140,820
$4,328,000 31 Dec 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.17%
137,775
$4,234,000 31 Dec 2017
13F
Casdin Capital, LLC
13F
Company
0.16%
133,333
$4,097,000 31 Dec 2017
13F
CAPITAL ADVISORS INC/OK
13F
Company
0.15%
122,424
$3,762,000 31 Dec 2017
13F
UBS Group AG
13F
Company
0.13%
111,091
$3,414,000 31 Dec 2017
13F
Granahan Investment Management, LLC
13F
Company
0.13%
106,201
$3,264,000 31 Dec 2017
13F
Russell Investments Group, Ltd.
13F
Company
0.12%
102,075
$3,198,000 31 Dec 2017
13F
CITIGROUP INC
13F
Company
0.12%
101,075
$3,106,000 31 Dec 2017
13F
Crestwood Advisors Group, LLC
13F
Company
0.1%
85,481
$2,627,000 31 Dec 2017
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.09%
76,872
$2,362,000 31 Dec 2017
13F
GUGGENHEIM CAPITAL LLC
13F
Company
0.09%
75,480
$2,319,000 31 Dec 2017
13F
NISA INVESTMENT ADVISORS, LLC
13F
Company
0.09%
71,400
$2,194,000 31 Dec 2017
13F
Ghost Tree Capital, LLC
13F
Company
0.08%
65,000
$1,997,000 31 Dec 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
0.07%
61,883
$1,902,000 31 Dec 2017
13F
Hudson Bay Capital Management LP
13F
Company
0.07%
60,000
$1,844,000 31 Dec 2017
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.07%
54,288
$1,668,000 31 Dec 2017
13F
Artal Group S.A.
13F
Company
0.06%
50,000
$1,537,000 31 Dec 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.06%
48,791
$1,500,000 31 Dec 2017
13F
Carnegie Investment Counsel
13F
Company
0.05%
39,600
$1,452,000 31 Dec 2017
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.06%
46,336
$1,424,000 31 Dec 2017
13F
Swiss National Bank
13F
Company
0.05%
44,800
$1,377,000 31 Dec 2017
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.05%
44,732
$1,375,000 31 Dec 2017
13F

Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q1 2018

As of 31 Mar 2018, Editas Medicine, Inc. - Common Stock (EDIT) was held by 192 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,152,906 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Capital World Investors, MORGAN STANLEY, ARK Investment Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Viking Global Investors LP, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 192 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders
146
Q1 2018 holders
192
Holder diff
46
Investor Q4 2017 Shares Q1 2018 Shares Share Diff Share Chg % Q4 2017 Value $ Q1 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.